Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China.
National Clinical Research Center for Obstetrics and Gynecology, Beijing, 100191, China.
Reprod Biol Endocrinol. 2018 Jul 6;16(1):64. doi: 10.1186/s12958-018-0382-6.
Unicornuate uterus, a congenital uterine malformation resulting from unilateral maldevelopment of Mullerian duct, is more prevalent in women with infertility. Owing to relative rarity of the condition, the evidence on the associated reproductive outcomes is derived from small heterogeneous studies that report different clinical endpoints and often do not account for the anatomical variations of unicornuate uterus. The aim of this study was to evaluate the embryological and clinical outcomes following IVF-ICSI treatment in women with unicornuate uterus without rudimentary functional cavity (ESHRE-ESGE class IVb).
Retrospective nested case-control study comprised 342 women with unicornuate uterus and 1026 matched controls who underwent IVF-ICSI cycles between October 2012 and October 2016. Cumulative live birth rate upon one complete IVF cycle, including transfers of all resulting embryos was considered as a primary outcome measure.
Baseline characteristics were comparable between the unicornuate uterus and control groups except for higher rate of primary infertility in unicornuate uterus. Ovarian response to stimulation did not differ between the groups. Transfer of day-3 embryos in fresh cycle resulted in lower clinical pregnancy rate (35.9% vs. 43.9%, p = 0.028) and live-birth rate (26.9% vs. 35.2%, p = 0.017) per transfer, but the difference was not observed when either cleavage frozen-thaw embryos or blastocysts were transferred. Implantation rate was lower and miscarriage rate was higher in women with unicornuate uterus but the difference between the groups did not reach statistical significance. Transfer of cleavage embryos resulted in significantly higher miscarriage rate and lower live-birth rate in fresh versus frozen-thaw cycles in each group, whereas fresh and frozen-thaw blastocyst embryos had comparable outcomes. Upon completion of one IVF-ICSI cycle, the cumulative pregnancy rate (53.1% vs. 65.7, p < 0.001) and cumulative live birth rate (42.4% vs. 54.6%, p < 0.001) were significantly lower in women with unicornuate uterus compared to those in women with normal uterus. Cumulative outcomes were superior when embryos were cultured to blastocyst stage.
Women with unicornuate uterus have lower clinical pregnancy and live birth rate after IVF-ICSI treatment compared to women with normal uterus. The treatment outcomes are improved with blastocyst culture, which warrants evaluation in prospective setting.
unicornuate 子宫是一种先天性子宫畸形,由 Müllerian 管单侧发育不良引起,在不孕女性中更为常见。由于该病症相对罕见,有关其相关生殖结局的证据来自于小型异质性研究,这些研究报告了不同的临床终点,且往往没有考虑 unicornuate 子宫的解剖学变异。本研究旨在评估 342 例无功能性残腔的 unicornuate 子宫(ESHRE-ESGE 分类 IVb)女性接受体外受精-卵胞浆内单精子注射(IVF-ICSI)治疗后的胚胎学和临床结局。
回顾性巢式病例对照研究纳入了 2012 年 10 月至 2016 年 10 月期间接受 IVF-ICSI 治疗的 342 例 unicornuate 子宫女性和 1026 例匹配对照。单次 IVF 周期的累积活产率(包括所有胚胎的转移)被视为主要结局指标。
unicornuate 子宫组和对照组的基线特征除 unicornuate 子宫组原发性不孕率较高外,其他特征无差异。两组的卵巢刺激反应无差异。新鲜周期移植第三天胚胎导致临床妊娠率(35.9% vs. 43.9%,p=0.028)和活产率(26.9% vs. 35.2%,p=0.017)降低,但移植卵裂期冷冻胚胎或囊胚时差异不明显。 unicornuate 子宫组的种植率较低,流产率较高,但两组间差异无统计学意义。新鲜周期移植卵裂期胚胎的流产率和活产率明显高于冷冻-解冻周期,而新鲜和冷冻-解冻囊胚胚胎的结局相似。完成一次 IVF-ICSI 周期后, unicornuate 子宫组的累积妊娠率(53.1% vs. 65.7%,p<0.001)和累积活产率(42.4% vs. 54.6%,p<0.001)明显低于正常子宫组。胚胎培养至囊胚期可提高累积结局。
unicornuate 子宫女性接受 IVF-ICSI 治疗后的临床妊娠率和活产率低于正常子宫女性。囊胚培养可改善治疗结局,值得在前瞻性研究中评估。